Editing David Boies (section)

=== Involvement with Theranos ===
Boies was a lawyer for blood-testing company [[Theranos]].{{sfn|Carreyrou|2018|p=182}} His dual roles as attorney and board member of the defunct company is recounted in the book, ''[[Bad Blood: Secrets and Lies in a Silicon Valley Startup]]''  by then ''The Wall Street Journal'' investigative reporter [[John Carreyrou]].{{sfn|Carreyrou|2018|p=182}} Boies, along with lawyers Heather King and Michael Brille, and his firm are described as protecting the startup using surveillance of witnesses and journalists, weaponized use of non-disclosure agreements and affidavits, intimidation tactics, and other heavy-handed practices.{{sfn|Carreyrou|2018|p=135}}{{sfn|Carreyrou|2018|p=247}} [[Boies Schiller Flexner LLP]] is portrayed by Carreyrou as acting as an extension of Theranos, including the use of the law firm's New York offices for hosting promotional meetings such as a faked blood test administered to ''[[Fortune (magazine)|Fortune]]'' writer [[Roger Parloff]].{{sfn|Carreyrou|2018|p=205-207}}

Boies also was on the Theranos board of directors,<ref name=canlearn>{{citation|url=https://www.law.com/therecorder/2021/08/27/what-other-firms-can-learn-from-boies-schillers-role-in-the-elizabeth-holmes-saga/|access-date=May 11, 2024|title=What Other Firms Can Learn From Boies Schiller's Role in the Elizabeth Holmes Saga|date=August 27, 2021|first=Alaina|last=Lancaster|work=Law.com}}</ref><ref>{{cite news |url=https://www.bizjournals.com/sanfrancisco/news/2016/11/21/lawyer-david-boies-theranos.html |work=www.bizjournals.com|title=Litigator David Boies parts ways with Theranos after disagreement over legal strategy}}</ref> raising questions about conflicts of interest.<ref name=":3">{{cite news |last1=Solomon |first1=Steven Davidoff |title=David Boies's Dual Roles at Theranos Set Up Conflict |url=https://www.nytimes.com/2016/02/03/business/dealbook/david-boiess-dual-roles-at-theranos-set-up-conflict.html |work=[[The New York Times]] |date=February 2, 2016}}</ref> Boies agreed to be paid for his firm's work in Theranos stock, which he expected to grow dramatically in value.<ref name=":3" /><ref name=pleads>{{citation|title=David Boies Pleads Not Guilty|date=September 21, 2018|work=[[The New York Times]]|access-date=May 11, 2024|url=https://www.nytimes.com/2018/09/21/business/david-boies-pleads-not-guilty.html|first=James B.|last=Stewart}}</ref> Boies' participation in and support for Theranos directly contributed to the misleading treatment of Walgreen patients, potentially resulting, cited within the report on Theranos by the federal agency CMS (Centers for Medicare & Medicaid Services), in "serious injury or harm, or death".<ref>{{citation|first=Alex|last=Gibney|authorlink=Alex Gibney|title=[[The Inventor: Out for Blood in Silicon Valley]]|year=2019|publisher=[[HBO Documentary Films]]}}</ref> Boies eventually left the Theranos board of directors, after the U.S. federal government had initiated multiple investigations into the firm.{{sfn|Carreyrou|2018|p=292}}